AYTU BIOPHARMA, INC short interest in 2020
In 2020, AYTU BIOPHARMA, INC's disclosed short interest ran from 39.17% of shares outstanding on 15 Jul 2020 to 48.57% on 15 Oct 2020, a change of +9.40 percentage points. The year's high was 49.76% on 30 Sep 2020 and its low 21.74% on 15 Sep 2020, averaging 34.50% across 7 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 3.22 days on 30 Sep 2020. Full history: AYTU BIOPHARMA, INC.
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2020 in figures
- Start of year
- 39.17% (15 Jul 2020)
- End of year
- 48.57% (15 Oct 2020)
- Change
- +9.40 pp
- High
- 49.76% (30 Sep 2020)
- Low
- 21.74% (15 Sep 2020)
- Average
- 34.50%
- Highest days to cover
- 3.22 (30 Sep 2020)
- SEC filings marked
- 9
Every report in 2020
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jul 2020 | 39.17% | 1.67 | results (8-K), 10-Q filed, results (8-K), results (8-K), 10-Q filed |
| 31 Jul 2020 | 32.78% | 1.29 | |
| 14 Aug 2020 | 26.34% | 1.85 | |
| 31 Aug 2020 | 23.14% | 1.43 | |
| 15 Sep 2020 | 21.74% | 1.78 | |
| 30 Sep 2020 | 49.76% | 3.22 | |
| 15 Oct 2020 | 48.57% | 2.40 | 10-K filed, results (8-K) |
See also: AYTU BIOPHARMA, INC's full history · most shorted US stocks of 2020 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.